The IPO for Fate Therapeutics, Inc. (Nasdaq: FATE) opened for trading at $6.56 after pricing 6,666,667 shares of its common ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE